NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Surface Modification of Cisplatin-Complexed Gold Nanoparticles and Its Influence on Colloidal Stability, Drug Loading, and Drug Release
Published
Author(s)
Jiaojie Tan, Tae Joon Cho, De-Hao Tsai, Jingyu Liu, John M. Pettibone, Rian You, Michael R. Zachariah, Vincent A. Hackley
Abstract
Cisplatin-complexed gold nanoparticles (PtII-AuNP) provide a promising strategy for chemo- radiation based anticancer drugs. Effective design of such platforms necessitates reliable assessment of surface engineering on a quantitative basis, and its influence on drug payload, stability and release. In this paper, polyethylene glycol (PEG) stabilized cisplatin-complexed AuNPs were synthesized as a model anti-tumor drug platform, where cisplatin (PtII) is attached via a dendrimer-like ligand. Surface modification and its influence on drug loading, colloidal stability and drug release were assessed. We show that upon complexation of PtII, colloidal stability decreases, but PEGylated AuNP conjugates (PtII-AuNP-dendron-SH-PEG) exhibit enhanced dispersion stability with an insignificant trade-off in drug loading capacity - compared with the non-PEGylated control. In this context, the effect of varying PEG concentration and molar mass was investigated. On a quantitative basis, the extent of PEGylation was characterized and its influence on dispersion stability and drug loading was examined using a novel, previously described electrospray differential mobility analyzer (ES-DMA) hyphenated with an inductively coupled plasma mass spectrometer (ICP-MS). Using ES-DMA-ICP-MS, AuNP conjugates were size- classified based on their electrical mobility, while PtII loading was simultaneously quantified by determination of Pt mass. Colloidal stability was quantitatively evaluated in biologically relevant media by ES-DMA-ICP-MS. Finally, PtII release performance was evaluated, and exhibited a clear pH dependence. Relative molecular mass of the PEG had no significant influence on PtII uptake or release performance, while PEGylation substantially improved the colloidal stability of the conjugate.
Tan, J.
, Cho, T.
, Tsai, D.
, Liu, J.
, Pettibone, J.
, You, R.
, Zachariah, M.
and Hackley, V.
(2017),
Surface Modification of Cisplatin-Complexed Gold Nanoparticles and Its Influence on Colloidal Stability, Drug Loading, and Drug Release, Langmuir, [online], https://doi.org/10.1021/acs.langmuir.7b02354, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=923210
(Accessed October 11, 2025)